Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study
- 執筆者
- 九州大学
種子島 時祥 - 試験名
- SNiP-RCC
- 雑誌
- Journal of Immunology
2024 May 17:ji2300308. - DOI
- DOI ↗
End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving
bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan Hematology Study Group (W-JHS) NHL01 trial
- 執筆者
- 九州大学
加藤 光次 - 試験名
- W-JHS NHL01
- 雑誌
- International Journal of Hematology
- DOI
- DOI ↗
The effect of human leukocyte antigen genotype on survival in advanced prostate cancer treated with primary androgen deprivation therapy: The KYUCOG-1401-A study
- 執筆者
- 九州大学
塩田 真己 - 試験名
- KYUCOG-1401A
- 雑誌
- Prostate Cancer & Prostatic Disease
- DOI
- DOI ↗
The effects of dienogest and combined oral contraceptives on protein S-specific activity in endometriosis patients
- 執筆者
- 九州大学
横田 奈津子 - 試験名
- SPADE
- 雑誌
- European Journal of Obstetrics & Gynecology and Reproductive Biology
- DOI
- DOI ↗
Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE trial
- 執筆者
- 北九州医療センター
松原 太一 - 試験名
- LOGIK2301
- 雑誌
- Clinical Lung Cancer
- DOI
- DOI ↗
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401
- 執筆者
- 原三信病院
横溝 晃 - 試験名
- KYUCOG-1401
- 雑誌
- International Journal of Urology
- DOI
- DOI ↗
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical Trial
- 執筆者
- 国立がんセンター中央病院
大熊 裕介 - 試験名
- TCOG_LC1901 (UNICORN)
- 雑誌
- JAMA Oncology
2024 Jan 1;10(1):43-51. - DOI
- DOI ↗
Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry
- 執筆者
- 九州大学
坪内 和哉 - 試験名
- 肺の生活習慣病コホート研究
- 雑誌
- BMJ Open Respiratory Research
- DOI
- DOI ↗
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: the SPIRAL-RT study
- 執筆者
- 京都府立医科大学
山田 忠明 - 試験名
- SPIRAL-RT
- 雑誌
- European Journal of Cancer
- DOI
- DOI ↗
A Phase II Single-Arm Study of Osimertinib for Radiotherapy-Naive CNS Metastasis Non-Small Cell Lung Cancer: Results for the First-line cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)
- 執筆者
- 静岡県立静岡がんセンター
和久田 一茂 - 試験名
- LOGIK1603
- 雑誌
- JTO Clinical and Research Reports
- DOI
- DOI ↗
Prospective exploration of a prognostic biomarker of nivolumab for head and neck cancer patients (BIONEXT)
- 執筆者
- 九州がんセンター
佐藤 晋彰 - 試験名
- BIO-NEXT
- 雑誌
- Preprint server
medRxiv - DOI
- DOI ↗
Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study)
- 執筆者
- 国立がんセンター中央病院
大熊 裕介 - 試験名
- TORG1938 (EPONA)
- 雑誌
- Future Oncology
2023 Jul;19(22):1515-1521. - DOI
- DOI ↗
A protocol of a single arm, prospective, open-label, multicenter, phase II study of ramucirumab and erlotinib in treatment-naïve non-small cell lung cancer patients with EGFR mutation and brain
metastases (SPIRAL-BRAIN study)
- 執筆者
- 京都府立医科大学
澤田 凌 - 試験名
- SPIRAL-BRAIN
- 雑誌
- Translational Lung Cancer Research
2023 Aug 30;12(8):1802-1806. - DOI
- DOI ↗
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study
- 執筆者
- 九州大学
Leandro Blas - 試験名
- SNiP-RCC
- 雑誌
- International Journal of Urology
2023 Sep;30(9):788-796. - DOI
- DOI ↗
Genome-wide association studies identified genetic polymorphisms associated with prognosis in patients undergoing primary androgen deprivation therapy for advanced prostate cancer: KYUCOG-1401-A study
- 執筆者
- 九州大学
塩田 真己 - 試験名
- KYUCOG-1401A
- 雑誌
- Endocr Relat Cancer
2023 Jun 1;30(7):e230044. - DOI
- DOI ↗
| 年度 | グループ名 | 試験名 | 論文名 | 雑誌 | DOI | 執筆者 |
|---|---|---|---|---|---|---|
| 2024年度 | その他 | SNiP-RCC | Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study | Journal of Immunology 2024 May 17:ji2300308. |
DOI ↗ | 九州大学 種子島 時祥 |
| 2023年度 | W-JHS | W-JHS NHL01 | End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan Hematology Study Group (W-JHS) NHL01 trial |
International Journal of Hematology | DOI ↗ | 九州大学 加藤 光次 |
| 2023年度 | KYUCOG | KYUCOG-1401A | The effect of human leukocyte antigen genotype on survival in advanced prostate cancer treated with primary androgen deprivation therapy: The KYUCOG-1401-A study | Prostate Cancer & Prostatic Disease | DOI ↗ | 九州大学 塩田 真己 |
| 2023年度 | その他 | SPADE | The effects of dienogest and combined oral contraceptives on protein S-specific activity in endometriosis patients | European Journal of Obstetrics & Gynecology and Reproductive Biology | DOI ↗ | 九州大学 横田 奈津子 |
| 2023年度 | LOGIK | LOGIK2301 | Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE trial | Clinical Lung Cancer | DOI ↗ | 北九州医療センター 松原 太一 |
| 2023年度 | KYUCOG | KYUCOG-1401 | GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401 | International Journal of Urology | DOI ↗ | 原三信病院 横溝 晃 |
| 2023年度 | TCOG | TCOG_LC1901 (UNICORN) | First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical Trial | JAMA Oncology 2024 Jan 1;10(1):43-51. |
DOI ↗ | 国立がんセンター中央病院 大熊 裕介 |
| 2023年度 | その他 | 肺の生活習慣病コホート研究 | Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry | BMJ Open Respiratory Research | DOI ↗ | 九州大学 坪内 和哉 |
| 2023年度 | SPIRAL | SPIRAL-RT | A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: the SPIRAL-RT study | European Journal of Cancer | DOI ↗ | 京都府立医科大学 山田 忠明 |
| 2023年度 | LOGIK | LOGIK1603 | A Phase II Single-Arm Study of Osimertinib for Radiotherapy-Naive CNS Metastasis Non-Small Cell Lung Cancer: Results for the First-line cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L) | JTO Clinical and Research Reports | DOI ↗ | 静岡県立静岡がんセンター 和久田 一茂 |
| 2023年度 | その他 | BIO-NEXT | Prospective exploration of a prognostic biomarker of nivolumab for head and neck cancer patients (BIONEXT) | Preprint server medRxiv |
DOI ↗ | 九州がんセンター 佐藤 晋彰 |
| 2023年度 | TORG | TORG1938 (EPONA) | Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study) | Future Oncology 2023 Jul;19(22):1515-1521. |
DOI ↗ | 国立がんセンター中央病院 大熊 裕介 |
| 2023年度 | SPIRAL | SPIRAL-BRAIN | A protocol of a single arm, prospective, open-label, multicenter, phase II study of ramucirumab and erlotinib in treatment-naïve non-small cell lung cancer patients with EGFR mutation and brain metastases (SPIRAL-BRAIN study) |
Translational Lung Cancer Research 2023 Aug 30;12(8):1802-1806. |
DOI ↗ | 京都府立医科大学 澤田 凌 |
| 2023年度 | その他 | SNiP-RCC | Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study | International Journal of Urology 2023 Sep;30(9):788-796. |
DOI ↗ | 九州大学 Leandro Blas |
| 2023年度 | KYUCOG | KYUCOG-1401A | Genome-wide association studies identified genetic polymorphisms associated with prognosis in patients undergoing primary androgen deprivation therapy for advanced prostate cancer: KYUCOG-1401-A study | Endocr Relat Cancer 2023 Jun 1;30(7):e230044. |
DOI ↗ | 九州大学 塩田 真己 |
